JPWO2019237152A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019237152A5 JPWO2019237152A5 JP2020569792A JP2020569792A JPWO2019237152A5 JP WO2019237152 A5 JPWO2019237152 A5 JP WO2019237152A5 JP 2020569792 A JP2020569792 A JP 2020569792A JP 2020569792 A JP2020569792 A JP 2020569792A JP WO2019237152 A5 JPWO2019237152 A5 JP WO2019237152A5
- Authority
- JP
- Japan
- Prior art keywords
- prebiotic
- sugar cane
- fiber material
- bowel disease
- inflammatory bowel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000000111 Saccharum officinarum Species 0.000 claims 19
- 235000007201 Saccharum officinarum Nutrition 0.000 claims 19
- 239000002657 fibrous material Substances 0.000 claims 19
- 235000013406 prebiotics Nutrition 0.000 claims 19
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 16
- 230000001580 bacterial effect Effects 0.000 claims 12
- 235000013305 food Nutrition 0.000 claims 12
- 230000000694 effects Effects 0.000 claims 11
- 239000006041 probiotic Substances 0.000 claims 11
- 230000000529 probiotic effect Effects 0.000 claims 11
- 235000018291 probiotics Nutrition 0.000 claims 11
- 230000004968 inflammatory condition Effects 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- 208000024891 symptom Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 239000002585 base Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 241000196324 Embryophyta Species 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018902145 | 2018-06-15 | ||
| AU2018902145A AU2018902145A0 (en) | 2018-06-15 | Preparation for the Treatment of Inflammatory Bowel Disease using a Whole Plant Fibre Extract from Sugarcane | |
| PCT/AU2019/050604 WO2019237152A1 (en) | 2018-06-15 | 2019-06-12 | Preparation for the treatment of inflammatory bowel disease using a whole plant fibre extract from sugarcane |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527104A JP2021527104A (ja) | 2021-10-11 |
| JPWO2019237152A5 true JPWO2019237152A5 (https=) | 2022-06-10 |
| JP2021527104A5 JP2021527104A5 (https=) | 2022-06-10 |
| JP7385930B2 JP7385930B2 (ja) | 2023-11-24 |
Family
ID=68841796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020569792A Active JP7385930B2 (ja) | 2018-06-15 | 2019-06-12 | サトウキビ由来の全植物繊維抽出物を使用した炎症性腸疾患の治療のための製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210138002A1 (https=) |
| EP (1) | EP3806879A4 (https=) |
| JP (1) | JP7385930B2 (https=) |
| AU (1) | AU2019285375B2 (https=) |
| CA (1) | CA3103831A1 (https=) |
| WO (1) | WO2019237152A1 (https=) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
| US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US11185518B2 (en) | 2017-12-19 | 2021-11-30 | Axcess Global Sciences, Llc | S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer |
| US10973786B2 (en) | 2016-03-11 | 2021-04-13 | Axcess Global Sciences, Llc | R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions |
| US10973792B2 (en) | 2019-02-13 | 2021-04-13 | Axcess Global Sciences, Llc | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use |
| US10736861B2 (en) | 2016-03-11 | 2020-08-11 | Axcess Global Sciences, Llc | Mixed salt compositions for producing elevated and sustained ketosis |
| US12109182B2 (en) | 2016-04-19 | 2024-10-08 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
| US12599579B2 (en) | 2016-04-19 | 2026-04-14 | Axcess Global Sciences, Llc | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids |
| US12496283B2 (en) | 2016-04-19 | 2025-12-16 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
| US20230346721A1 (en) | 2018-04-18 | 2023-11-02 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| US12329734B2 (en) | 2017-12-19 | 2025-06-17 | Axcess Global Sciences, Llc | Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow |
| US12521378B2 (en) | 2016-04-19 | 2026-01-13 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans |
| US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| US12533346B2 (en) | 2016-04-19 | 2026-01-27 | Axcess Global Sciences, Llc | Administration of berberine metabolites |
| US12090129B2 (en) | 2017-11-22 | 2024-09-17 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US11129802B2 (en) | 2018-08-27 | 2021-09-28 | Axcess Global Sciences, Llc | Compositions and methods for delivering cannabidiol and ketone bodies |
| US11241401B2 (en) | 2020-02-06 | 2022-02-08 | Axcess Global Sciences, Llc | Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions |
| US11419836B2 (en) | 2019-02-13 | 2022-08-23 | Axcess Global Sciences, Llc | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions |
| US10980772B2 (en) | 2018-08-27 | 2021-04-20 | Axcess Global Sciences, Llc | Compositions and methods for delivering tetrahydrocannabinol and ketone bodies |
| US12472200B2 (en) * | 2019-05-15 | 2025-11-18 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
| US12167993B2 (en) | 2019-06-21 | 2024-12-17 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
| US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11033553B2 (en) | 2019-06-21 | 2021-06-15 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US12186297B2 (en) | 2020-08-26 | 2025-01-07 | Axcess Global Sciences, Llc | Compositions and methods for increasing lean-to-fat mass ratio |
| WO2024026529A1 (en) * | 2022-08-01 | 2024-02-08 | Health Food Symmetry Pty Ltd | Preparation for the treatment of non-alcoholic fatty liver disease (nafld) |
| BE1031643B1 (nl) * | 2023-05-26 | 2025-01-03 | Synero Bv | Functionele drank alsook werkwijze voor het vervaardigen en stabiliseren hiervan |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO320546B1 (no) * | 2003-12-12 | 2005-12-19 | Nova Biotics As | Prebiotiske kombinasjonsprodukter |
| US20060093592A1 (en) * | 2004-10-04 | 2006-05-04 | Nutracea | Synbiotics |
| US20080227753A1 (en) | 2007-02-26 | 2008-09-18 | Kun Lian | Nano-sized Bagasse Fiber |
| US9245263B2 (en) * | 2009-06-23 | 2016-01-26 | Jwl Ip Holdings Llc | Systems and methods for scripted content delivery |
| AU2010300088A1 (en) | 2009-09-23 | 2012-05-17 | Kfsu Pty Ltd | The production of fibre from plant material |
| PL2515937T3 (pl) | 2009-12-22 | 2020-05-18 | Probi Ab | Niesfermentowane kompozycje zawierające frakcję zbożową i probiotyk oraz ich zastosowania |
| JP6549376B2 (ja) | 2012-03-05 | 2019-07-24 | グラタク テクノロジーズ ピーティーワイ リミテッド | 栄養補助食品 |
| US20160067299A1 (en) * | 2013-04-05 | 2016-03-10 | Gratuk Technologies Pty Ltd | Use of dietary fibre supplement in a food formulation |
| CN103355728A (zh) * | 2013-07-01 | 2013-10-23 | 福建省农业科学院农业工程技术研究所 | 一种果汁的固定化半连续乳酸发酵方法 |
| AU2014349787A1 (en) * | 2013-11-18 | 2016-07-07 | Kfsu Ltd | Dietary supplement for the treatment of acid reflux and gastro-oesophageal reflux disease (GORD/GERD) |
| JP5852207B2 (ja) | 2013-11-29 | 2016-02-03 | 喜信 大城 | サトウキビの難消化性食物繊維の製造方法 |
| JP2015202057A (ja) | 2014-04-11 | 2015-11-16 | 喜信 大城 | 食物繊維入りヨーグルトの製造方法 |
| JP6306170B2 (ja) * | 2014-05-24 | 2018-04-04 | アテリオ・バイオ株式会社 | 難消化性物質及びその製造方法 |
| US10245294B2 (en) * | 2014-06-13 | 2019-04-02 | Gratuk Technologies Pty Ltd | Dietary supplement |
| CN104814365A (zh) * | 2015-05-29 | 2015-08-05 | 郭心仪 | 鹅饲料的制备方法 |
| CN105685486A (zh) * | 2016-01-29 | 2016-06-22 | 刘健 | 一种天然高纤维无臭型牛羊饲料的制备方法 |
| CN106883968A (zh) * | 2017-04-24 | 2017-06-23 | 贵州省仁怀市茅台镇永泰酒业股份有限公司 | 一种杨梅果酒生产方法 |
-
2019
- 2019-06-12 JP JP2020569792A patent/JP7385930B2/ja active Active
- 2019-06-12 US US17/251,135 patent/US20210138002A1/en active Pending
- 2019-06-12 CA CA3103831A patent/CA3103831A1/en active Pending
- 2019-06-12 WO PCT/AU2019/050604 patent/WO2019237152A1/en not_active Ceased
- 2019-06-12 EP EP19820443.0A patent/EP3806879A4/en active Pending
- 2019-06-12 AU AU2019285375A patent/AU2019285375B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019237152A5 (https=) | ||
| JP2021527104A5 (https=) | ||
| US10617728B2 (en) | Probiotics and prebiotics compound preparation and processing method thereof | |
| JP4200518B2 (ja) | 代謝症候群に関与する危険因子を減少するＬａｃｔｏｂａｃｉｌｌｕｓ株の使用 | |
| CN116270773A (zh) | 黄金奇异果组合物及其制备和使用方法 | |
| JP2019520340A5 (https=) | ||
| CN102458152A (zh) | 具有β-1,3和β-1,4/1,6键的β-低聚半乳糖的协同混合物 | |
| KR102544149B1 (ko) | 락토바실러스 헬베티쿠스 균주 및 이를 포함하는 염증성 질환의 예방 또는 치료용 조성물 | |
| US20210338749A1 (en) | Methods of treatment of inflammatory conditions and associated infections | |
| RU2018139655A (ru) | Бифидобактерии для увеличения безжировой массы тела | |
| CN114672436B (zh) | 一株嗜酸乳杆菌及其应用 | |
| CN119343144A (zh) | 发酵乳杆菌菌株单独或与酿酒酵母组合用于预防和/或治疗阴道念珠菌病的用途 | |
| KR20190143337A (ko) | 류코노스톡속 균주를 포함하는 장 기능 개선용 조성물 | |
| CN112023030A (zh) | 一种护理骨关节新组氨糖益生菌骨胶原蛋白肽配方 | |
| CN112888448B (zh) | 单形巨单胞菌在预防和/或治疗代谢性疾病中的用途 | |
| CN110777098A (zh) | 一种具有防治糖尿病脑病功效的乳杆菌及其分离方法和应用 | |
| Wei et al. | The impact of combined therapy with Lactobacillus acidophilus and montmorillonite powder on the inflammatory response in pediatric rotavirus enteritis | |
| CN115119940A (zh) | 嗜酸乳杆菌LA85和乳双歧杆菌BLa80在抑制幽门螺旋杆菌上的应用 | |
| Guo et al. | Bifidobacterium adolescentis CCFM1285 combined with yeast β-glucan alleviates the gut microbiota and metabolic disturbances in mice with antibiotic-associated diarrhea | |
| JP2010280602A (ja) | 抗アレルギー組成物 | |
| TW202408556A (zh) | 通便改善劑 | |
| US20230302066A1 (en) | Probiotic composition for treatment of oral candida infections | |
| CN117241808A (zh) | 用于治疗和预防胃肠炎症的组合物和方法 | |
| KR102954041B1 (ko) | 항비만 활성을 갖는 와이셀라 시바리아 gskm06 (kctc15129bp) 대사산물 및 이를 포함하는 항비만 조성물 | |
| Li et al. | Research progress of traditional Chinese medicine compound in the treatment of gout based on intestinal flora |